Standout Papers

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review 2018 2026 2020 2023 328
  1. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review (2018)
    Ricardo Costa, Hyo S. Han et al. Breast Cancer Research and Treatment

Immediate Impact

2 by Nobel laureates 4 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
2 intermediate papers

Works of Ricardo Costa being referenced

Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond
2020

Author Peers

Author Last Decade Papers Cites
Ricardo Costa 1104 577 525 822 79 2.1k
Laura Boldrini 906 724 644 1144 96 2.4k
G. Deplanque 1259 788 530 624 76 2.2k
Luigi Formisano 1079 751 484 1120 73 2.1k
Jeanine M.L. Roodhart 1223 390 628 1002 82 2.2k
Ingeborg Tinhofer 1388 610 834 861 74 2.5k
Yutaka Hatanaka 1157 644 517 699 138 2.2k
Francesco Pantano 955 529 562 840 106 2.0k
Raffael Kurek 1000 715 553 954 38 2.2k
Joe Stephenson 1077 476 354 877 65 2.0k
Stephen Leong 1104 461 596 829 72 2.2k

All Works

Loading papers...

Rankless by CCL
2026